The novel therapy of the medication represents a major breakthrough in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide545759.onesmablog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-83495112